Company Filing History:
Years Active: 2006
Title: Pratisksha Patel: Innovator in Monoclonal Antibody Research
Introduction
Pratisksha Patel is a notable inventor based in Marietta, GA (US). He has made significant contributions to the field of biomedical research, particularly in the development of monoclonal antibodies. His work focuses on innovative methods to combat infections caused by staphylococcal bacteria.
Latest Patents
Pratisksha Patel holds a patent for "Monoclonal antibodies to the fibronectin binding protein and method of use in treating or preventing infections." This invention involves monoclonal antibodies that can bind to the fibronectin binding protein B (Fnbp) of staphylococcal bacteria. These antibodies are generated from a peptide from the D2 region of Fnbp and are designed to prevent the adherence of staph bacteria to host cells. The high affinity of these antibodies makes them advantageous in inhibiting the binding ability of Fnbp to fibronectin, thereby offering a potential method for treating and preventing infections.
Career Highlights
Pratisksha Patel has been associated with Inhibitex, Inc., where he has contributed to groundbreaking research in the field of infectious diseases. His innovative approach to developing monoclonal antibodies has positioned him as a key figure in the fight against bacterial infections.
Collaborations
Throughout his career, Pratisksha has collaborated with esteemed colleagues such as Joseph M. Patti and Andrea Hall. These collaborations have further enhanced the research and development of effective treatments against infections.
Conclusion
Pratisksha Patel's work in monoclonal antibody research exemplifies the impact of innovation in the medical field. His contributions are paving the way for new treatments that can significantly improve patient outcomes.